RAYMOND JAMES & ASSOCIATES - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 1 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$448,000
-66.5%
22,207
-38.0%
0.00%
-100.0%
Q2 2021$1,337,000
+78.7%
35,835
+22.4%
0.00%0.0%
Q1 2021$748,000
+53.6%
29,272
+32.3%
0.00%0.0%
Q4 2020$487,000
+20.2%
22,124
-1.6%
0.00%0.0%
Q3 2020$405,000
-29.1%
22,495
+0.1%
0.00%0.0%
Q2 2020$571,000
+37.3%
22,478
-0.7%
0.00%0.0%
Q1 2020$416,000
-23.2%
22,633
-8.0%
0.00%0.0%
Q4 2019$542,000
+54.4%
24,611
+0.7%
0.00%
Q3 2019$351,00024,4460.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,705,392$43,607,0007.88%
Bain Capital Life Sciences Investors, LLC 3,080,237$78,762,0004.46%
DAFNA Capital Management LLC 587,756$15,029,0003.57%
RTW INVESTMENTS, LP 7,463,291$190,836,0002.98%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$5,114,0002.79%
Evolutionary Tree Capital Management, LLC 122,473$3,132,0001.85%
Parkman Healthcare Partners LLC 303,268$7,755,0001.80%
Eagle Health Investments LP 161,125$4,120,0001.62%
BRIDGER MANAGEMENT, LLC 588,910$15,058,0001.41%
Woodline Partners LP 1,777,000$45,438,0001.01%
View complete list of DICERNA PHARMACEUTICALS INC shareholders